{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:39:40Z","timestamp":1794688780489,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28718-8","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T06:01:54Z","timestamp":1763877714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-22 attenuates MAFLD progression by modulating oxidative stress and ferroptosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Suxia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"28718_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. International consensus Panel. MAFLD: A consensus-Driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014e1 (2020).","journal-title":"Gastroenterology"},{"key":"28718_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3748\/wjg.v29.i1.126","volume":"29","author":"MS Jeeyavudeen","year":"2023","unstructured":"Jeeyavudeen, M. S., Khan, S., Fouda, S. & Pappachan, J. M. Management of metabolic-associated fatty liver disease: the diabetology perspective. World J. Gastroenterol. 29, 126\u2013143 (2023).","journal-title":"World J. Gastroenterol."},{"key":"28718_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology 158, 1851\u20131864 (2020).","journal-title":"Gastroenterology"},{"key":"28718_CR4","doi-asserted-by":"publisher","first-page":"155835","DOI":"10.1016\/j.metabol.2024.155835","volume":"154","author":"M Kokkorakis","year":"2024","unstructured":"Kokkorakis, M. et al. Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges. Metabolism 154, 155835 (2024).","journal-title":"Metabolism"},{"key":"28718_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048 (2016).","journal-title":"Metabolism"},{"key":"28718_CR6","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng, C., Stewart, A. G., Woodman, O. L., Ritchie, R. H. & Qin, C. X. Non-Alcoholic steatohepatitis: A review of its Mechanism, models and medical treatments. Front. Pharmacol. 11, 603926 (2020).","journal-title":"Front. Pharmacol."},{"key":"28718_CR7","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3390\/ijms19092706","volume":"19","author":"CM Sena","year":"2018","unstructured":"Sena, C. M., Cipriano, M. A., Botelho, M. F. & Sei\u00e7a, R. M. Lipoic acid prevents High-Fat Diet-Induced hepatic steatosis in Goto Kakizaki rats by reducing oxidative stress through Nrf2 activation. Int. J. Mol. Sci. 19, 2706 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"28718_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","volume":"10","author":"H Motohashi","year":"2004","unstructured":"Motohashi, H. & Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549\u2013557 (2004).","journal-title":"Trends Mol. Med."},{"key":"28718_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"28718_CR10","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson, M., Castro-Portuguez, R. & Zhang, D. D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23, 101107 (2019).","journal-title":"Redox Biol."},{"key":"28718_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki, S. et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell. Death Dis. 10, 449 (2019).","journal-title":"Cell. Death Dis."},{"key":"28718_CR12","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/biomedicines9121912","volume":"9","author":"W Zai","year":"2021","unstructured":"Zai, W., Chen, W., Liu, H. & Ju, D. Therapeutic opportunities of IL-22 in Non-Alcoholic fatty liver disease: from molecular mechanisms to clinical applications. Biomedicines 9, 1912 (2021).","journal-title":"Biomedicines"},{"key":"28718_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov, J. A., Hanash, A. M. & van den Brink, M. R. Interleukin-22: immunobiology and pathology. Annu. Rev. Immunol. 33, 747\u2013785 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"28718_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hep.31031","volume":"72","author":"S Hwang","year":"2020","unstructured":"Hwang, S. et al. Interleukin-22 ameliorates Neutrophil-Driven nonalcoholic steatohepatitis through multiple targets. Hepatology 72, 412\u2013429 (2020).","journal-title":"Hepatology"},{"key":"28718_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/hep.23837","volume":"52","author":"SH Ki","year":"2010","unstructured":"Ki, S. H. et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52, 1291\u20131300 (2010).","journal-title":"Hepatology"},{"key":"28718_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1271\/bbb.110061","volume":"75","author":"WW Xing","year":"2011","unstructured":"Xing, W. W. et al. Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice. Biosci. Biotechnol. Biochem. 75, 1290\u20131294 (2011).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"28718_CR17","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1021\/acsami.8b19717","volume":"11","author":"W Zai","year":"2019","unstructured":"Zai, W. et al. Targeted Interleukin-22 gene delivery in the liver by Polymetformin and Penetratin-Based hybrid nanoparticles to treat nonalcoholic fatty liver disease. ACS Appl. Mater. Interfaces. 11, 4842\u20134857 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"28718_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/acer.15021","volume":"47","author":"YX Meng","year":"2023","unstructured":"Meng, Y. X., Zhao, R. & Huo, L. J. Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K\/AKT\/mTOR pathway in mice. Alcohol Clin. Exp. Res. (Hoboken). 47, 448\u2013458 (2023).","journal-title":"Alcohol Clin. Exp. Res. (Hoboken)"},{"key":"28718_CR19","doi-asserted-by":"publisher","first-page":"118677","DOI":"10.1016\/j.lfs.2020.118677","volume":"264","author":"SB Su","year":"2021","unstructured":"Su, S. B. et al. Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis. Life Sci. 264, 118677 (2021).","journal-title":"Life Sci."},{"key":"28718_CR20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3748\/wjg.v23.i11.2002","volume":"23","author":"YH Ni","year":"2017","unstructured":"Ni, Y. H., Huo, L. J. & Li, T. T. Antioxidant axis Nrf2-keap1-ARE in Inhibition of alcoholic liver fibrosis by IL-22. World J. Gastroenterol. 23, 2002\u20132011 (2017).","journal-title":"World J. Gastroenterol."},{"key":"28718_CR21","doi-asserted-by":"publisher","first-page":"102617","DOI":"10.1016\/j.clinre.2025.102617","volume":"49","author":"X Xu","year":"2025","unstructured":"Xu, X. et al. Interleukin-22 ameliorates alcohol-associated liver fibrosis via Nrf2-ARE signaling: mechanistic insights and clinical correlations. Clin. Res. Hepatol. Gastroenterol. 49, 102617 (2025).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"28718_CR22","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.25744","volume":"56","author":"X Kong","year":"2012","unstructured":"Kong, X. et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56, 1150\u20131159 (2012).","journal-title":"Hepatology"},{"key":"28718_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3748\/wjg.v21.i5.1531","volume":"21","author":"DH Lu","year":"2015","unstructured":"Lu, D. H. et al. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines. World J. Gastroenterol. 21, 1531\u20131545 (2015).","journal-title":"World J. Gastroenterol."},{"key":"28718_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","volume":"16","author":"KY Tang","year":"2019","unstructured":"Tang, K. Y. et al. Safety, pharmacokinetics, and biomarkers of F-652, a Recombinant human interleukin-22 dimer, in healthy subjects. Cell. Mol. Immunol. 16, 473\u2013482 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"28718_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.31046","volume":"72","author":"JP Arab","year":"2020","unstructured":"Arab, J. P. et al. An Open-Label, Dose-Escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with Alcohol-associated hepatitis. Hepatology 72, 441\u2013453 (2020).","journal-title":"Hepatology"},{"key":"28718_CR26","first-page":"43","volume":"1","author":"H Pan","year":"2004","unstructured":"Pan, H., Hong, F., Radaeva, S. & Gao, B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from Concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1, 43\u201349 (2004).","journal-title":"Cell. Mol. Immunol."},{"key":"28718_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva, S., Sun, R., Pan, H. N., Hong, F. & Gao, B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332\u20131342 (2004).","journal-title":"Hepatology"},{"key":"28718_CR28","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.7150\/thno.43894","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury. Theranostics 10, 5879\u20135894 (2020).","journal-title":"Theranostics"},{"key":"28718_CR29","doi-asserted-by":"publisher","first-page":"28990","DOI":"10.1038\/srep28990","volume":"6","author":"M Gulhane","year":"2016","unstructured":"Gulhane, M. et al. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci. Rep. 6, 28990 (2016).","journal-title":"Sci. Rep."},{"key":"28718_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","volume":"514","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237\u2013241 (2014).","journal-title":"Nature"},{"key":"28718_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"28718_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmed.2020.00071","volume":"7","author":"Q Yao","year":"2020","unstructured":"Yao, Q., Li, S., Li, X., Wang, F. & Tu, C. Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis. Front. Med. (Lausanne). 7, 71 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"28718_CR33","doi-asserted-by":"crossref","unstructured":"Chambel, S. S., Santos-Gon\u00e7alves, A. & Duarte, T. L. The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism. Biomed Res Int 597134 (2015).\u00a0","DOI":"10.1155\/2015\/597134"},{"key":"28718_CR34","doi-asserted-by":"publisher","first-page":"155756","DOI":"10.1016\/j.phymed.2024.155756","volume":"130","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD. Phytomedicine 130, 155756 (2024).","journal-title":"Phytomedicine"},{"key":"28718_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","volume":"74","author":"A Mohs","year":"2021","unstructured":"Mohs, A. et al. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis. J. Hepatol. 74, 638\u2013648 (2021).","journal-title":"J. Hepatol."},{"key":"28718_CR36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A. & Dulak, J. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell. Mol. Life Sci. 73, 3221\u20133247 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"28718_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jhep.2004.11.040","volume":"42","author":"L Malaguarnera","year":"2005","unstructured":"Malaguarnera, L., Madeddu, R., Palio, E., Arena, N. & Malaguarnera, M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J. Hepatol. 42, 585\u2013591 (2005).","journal-title":"J. Hepatol."},{"key":"28718_CR38","doi-asserted-by":"crossref","unstructured":"Du, J. et al. Heme Oxygenase-1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis-Related Liver Fibrosis. Biomed Res Int 4910601 (2020).\u00a0","DOI":"10.1155\/2020\/4910601"},{"key":"28718_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41387-024-00300-7","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease. Nutr. Diabetes. 14, 41 (2024).","journal-title":"Nutr. Diabetes"},{"key":"28718_CR40","doi-asserted-by":"publisher","first-page":"115717","DOI":"10.1016\/j.ecoenv.2023.115717","volume":"268","author":"L Zhu","year":"2023","unstructured":"Zhu, L., Zhang, Q., Hua, C. & Ci, X. Melatonin alleviates particulate matter-induced liver fibrosis by inhibiting ROS-mediated mitophagy and inflammation via Nrf2 activation. Ecotoxicol. Environ. Saf. 268, 115717 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"28718_CR41","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli, C., Chio, I. & Tuveson, D. A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 29, 1727\u20131745 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"28718_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JA Del Campo","year":"2018","unstructured":"Del Campo, J. A., Gallego, P. & Grande, L. Role of inflammatory response in liver diseases: therapeutic strategies. World J. Hepatol. 10, 1\u20137 (2018).","journal-title":"World J. Hepatol."},{"key":"28718_CR43","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/antiox10121864","volume":"10","author":"D Mancardi","year":"2021","unstructured":"Mancardi, D., Mezzanotte, M., Arrigo, E., Barinotti, A. & Roetto, A. Iron Overload, oxidative Stress, and ferroptosis in the failing heart and liver. Antioxid. (Basel). 10, 1864 (2021).","journal-title":"Antioxid. (Basel)"},{"key":"28718_CR44","doi-asserted-by":"publisher","first-page":"113374","DOI":"10.1016\/j.biopha.2022.113374","volume":"153","author":"S Wang","year":"2022","unstructured":"Wang, S., Liu, Z., Geng, J., Li, L. & Feng, X. An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed. Pharmacother. 153, 113374 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"28718_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell. Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"28718_CR46","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/DMSO.S361187","volume":"15","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Hyperferritinemia correlates to metabolic dysregulation and steatosis in Chinese Biopsy-Proven nonalcoholic fatty liver disease patients. Diabetes Metab. Syndr. Obes. 15, 1543\u20131552 (2022).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"28718_CR47","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.cmet.2024.07.013","volume":"36","author":"L Tao","year":"2024","unstructured":"Tao, L. et al. Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH. Cell. Metab. 36, 2190\u20132206e5 (2024).","journal-title":"Cell. Metab."},{"key":"28718_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","volume":"190","author":"J Qi","year":"2020","unstructured":"Qi, J., Kim, J. W., Zhou, Z., Lim, C. W. & Kim, B. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid Peroxidation-Mediated cell death in mice. Am. J. Pathol. 190, 68\u201381 (2020).","journal-title":"Am. J. Pathol."},{"key":"28718_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","volume":"17","author":"Y Honda","year":"2017","unstructured":"Honda, Y. et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 17, 96 (2017).","journal-title":"BMC Gastroenterol."},{"key":"28718_CR50","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen, X., Li, J., Kang, R., Klionsky, D. J. & Tang, D. Ferroptosis: machinery and regulation. Autophagy 17, 2054\u20132081 (2021).","journal-title":"Autophagy"},{"key":"28718_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-025-07621-0","volume":"16","author":"C Huang","year":"2025","unstructured":"Huang, C. et al. TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. Cell. Death Dis. 16, 287 (2025).","journal-title":"Cell. Death Dis."},{"key":"28718_CR52","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.3390\/ijms23158300","volume":"23","author":"SE Machado","year":"2022","unstructured":"Machado, S. E. et al. Counteraction of myocardial ferritin heavy chain deficiency by Heme Oxygenase-1. Int. J. Mol. Sci. 23, 8300 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"28718_CR53","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh, A. et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-Deficient NSCLC tumors. ACS Chem. Biol. 11, 3214\u20133225 (2016).","journal-title":"ACS Chem. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28718-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:04:08Z","timestamp":1777125848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28718-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28718"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28718-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45166"}}